Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 103

1.

Impaired Capacity of Fibroblasts to Support Airway Epithelial Progenitors in Bronchiolitis Obliterans Syndrome.

Zhang SB, Sun X, Wu Q, Wu JP, Chen HY.

Chin Med J (Engl). 2016 5th Sep;129(17):2040-4. doi: 10.4103/0366-6999.189058.

2.

Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study.

Di Carlo S, Rossi E, Politano G, Inghilleri S, Morbini P, Calabrese F, Benso A, Savino A, Cova E, Zampieri D, Meloni F.

PLoS One. 2016 Aug 26;11(8):e0161771. doi: 10.1371/journal.pone.0161771. eCollection 2016.

3.

Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans.

Calabrese C, Corcione N, Rea G, Stefanelli F, Meoli I, Vatrella A.

J Bras Pneumol. 2016 May-Jun;42(3):228-31. doi: 10.1590/S1806-37562016000000043. English, Portuguese.

4.

Evaluating bronchodilator response in pediatric patients with post-infectious bronchiolitis obliterans: use of different criteria for identifying airway reversibility.

Mattiello R, Vidal PC, Sarria EE, Pitrez PM, Stein RT, Mocelin HT, Fischer GB, Jones MH, Pinto LA.

J Bras Pneumol. 2016 May-Jun;42(3):174-8. doi: 10.1590/S1806-37562015000000065. English, Portuguese.

5.

HMGB1 exacerbates bronchiolitis obliterans syndrome via RAGE/NF-κB/HPSE signaling to enhance latent TGF-β release from ECM.

He L, Sun F, Wang Y, Zhu J, Fang J, Zhang S, Yu Q, Gong Q, Ren B, Xiang X, Chen Z, Ning Q, Hu J, Yang P, Wang CY.

Am J Transl Res. 2016 May 15;8(5):1971-84. eCollection 2016.

6.
7.

Phenytoin induced Steven-Johnson syndrome and bronchiolitis obliterans - case report and review of literature.

Pannu BS, Egan AM, Iyer VN.

Respir Med Case Rep. 2016 Jan 20;17:54-6. doi: 10.1016/j.rmcr.2016.01.006. eCollection 2016.

8.

Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.

Rhee CK, Ha JH, Yoon JH, Cho BS, Min WS, Yoon HK, Lee JW.

Yonsei Med J. 2016 Mar;57(2):365-72. doi: 10.3349/ymj.2016.57.2.365.

9.
10.

Pulmonary hypertension associated with bronchiolitis obliterans after hematopoietic stem cell transplantation.

Pate A, Rotz S, Warren M, Hirsch R, Cash M, Myers KC, El-Bietar J, Nelson A, Wallace G, Filipovich AH, Bleesing J, Chima RS, Davies SM, Jodele S, Dandoy CE.

Bone Marrow Transplant. 2016 Feb;51(2):310-2. doi: 10.1038/bmt.2015.248. Epub 2015 Oct 19. No abstract available.

11.

Sauropus androgynus (L.) Merr. Induced Bronchiolitis Obliterans: From Botanical Studies to Toxicology.

Bunawan H, Bunawan SN, Baharum SN, Noor NM.

Evid Based Complement Alternat Med. 2015;2015:714158. doi: 10.1155/2015/714158. Epub 2015 Aug 27. Review.

12.

Acute graft-versus-host disease and bronchiolitis obliterans after autologous stem cell transplantation in a patient with multiple myeloma.

Alonso S, Cabrero M, Caballero JC, Dávila J, de la Calle VG, López-Godino O, López-Corral L, Pérez E, Vázquez L, Corral R, Caballero D, Del Cañizo C, Mateos MV.

Clin Case Rep. 2015 Jun;3(6):370-5. doi: 10.1002/ccr3.231. Epub 2015 Apr 9.

13.

Clinical features of post-infectious bronchiolitis obliterans in children undergoing long-term azithromycin treatment.

Wang X, Liu C, Wang M, Zhang YI, Li H, Liu G.

Exp Ther Med. 2015 Jun;9(6):2379-2383. Epub 2015 Apr 8.

14.

MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation.

Xu Z, Ramachandran S, Gunasekaran M, Zhou F, Trulock E, Kreisel D, Hachem R, Mohanakumar T.

J Heart Lung Transplant. 2015 Sep;34(9):1154-62. doi: 10.1016/j.healun.2015.03.021. Epub 2015 Mar 27.

15.

Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans.

Mimura T, Walker N, Aoki Y, Manning CM, Murdock BJ, Myers JL, Lagstein A, Osterholzer JJ, Lama VN.

Am J Pathol. 2015 Jun;185(6):1564-74. doi: 10.1016/j.ajpath.2015.03.002. Epub 2015 Apr 4.

16.

Correction: Cardiac mass and function decrease in bronchiolitis obliterans syndrome after lung transplantation: relationship to physical activity?

PLOS ONE Staff.

PLoS One. 2015 Mar 19;10(3):e0119999. doi: 10.1371/journal.pone.0119999. eCollection 2015. No abstract available.

17.

A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.

Corris PA, Ryan VA, Small T, Lordan J, Fisher AJ, Meachery G, Johnson G, Ward C.

Thorax. 2015 May;70(5):442-50. doi: 10.1136/thoraxjnl-2014-205998. Epub 2015 Feb 24.

18.

Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.

Abedin S, Yanik GA, Braun T, Pawarode A, Magenau J, Goldstein SC, Levine JE, Kitko CL, Couriel DR.

Biol Blood Marrow Transplant. 2015 Jun;21(6):1127-31. doi: 10.1016/j.bbmt.2015.02.006. Epub 2015 Feb 14.

19.

Bronchiolitis obliterans associated with Stevens-Johnson syndrome: a case report.

Park H, Ko YB, Kwon HS, Lim CM.

Yonsei Med J. 2015 Mar;56(2):578-81. doi: 10.3349/ymj.2015.56.2.578.

20.

Current research on pediatric patients with bronchiolitis obliterans in Brazil.

Tomikawa SO, Rodrigues JC.

Intractable Rare Dis Res. 2015 Feb;4(1):7-11. doi: 10.5582/irdr.2014.01020. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk